These publications were authored or co-authored by Quest Diagnostics staff.
Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: results of a phase 1/2 study.Authors: Richardson PG, Chanan-Khan AA, Lonial S, Krishnan AY, Carroll MP, Alsina M, Albitar M, Berman D, Messina M, Anderson KC.
Br J Haematol. 2011;153:729-740.
Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer.Authors: Sanders HR, Li HR, Bruey JM, Scheerle JA, Meloni-Ehrig AM, Kelly JC, Novick C, Albitar M
Cancer Genet. 2011;204:45-52.
The contribution of a 9p21.3 variant, a KIF6 variant, and C-reactive protein to predicting risk of myocardial infarction in a prospective study.Authors: Shiffman D, O'Meara ES, Rowland CM, Louie JZ, Cushman M, Tracy RP, Devlin JJ, Psaty BM.
BMC Cardiovasc Disord. 2011;11:10.
Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals.Authors: Shikuma CM, Ribaudo HJ, Zheng Y, Gulick RM, Meyer WA, Tashima KT, Bastow B, Kuritzkes DR, Glesby MJ.
AIDS Res Hum Retroviruses. 2011;27:461-468.
The dangers of including nonclassical cystic fibrosis variants in population-based screening panels: p.L997F, further genotype/phenotype correlation data.Quest Diagnostics Authors: Strom, C
Authors: Redman JB, Peng M.
Genet Med. 2011;13:1042-1044.
Authors: Crossley B, Buller-Buerkle A, Jarvis M, Quan F, Peng M, Muralidharan K, Pratt V, Redman JB, Sun W.
Genet Med. 2011;13:166-172.
Testing for variants in CYP2C19: population frequencies and testing experience in a clinical laboratory.Quest Diagnostics Authors: Strom, C
Authors: Goos D, Crossley B, Zhang K, Buller-Burkle A, Jarvis M, Quan F, Peng M, Sun W.
Genet Med. 2012;14:95-100.
Genetic testing for early detection of individuals at risk of coronary heart disease and monitoring response to therapy: challenges and promises.Authors: Superko HR, Roberts R, Agatston A, Frohwein S, Reingold JS, White TJ, Sninsky JJ, Margolis B, Momary KM, Garrett BC, King SB, III.
Curr Atheroscler Rep. 2011;13:396-404.
Detection of circulating tumor cells in human peripheral blood using surface-enhanced Raman scattering nanoparticles.Authors: Wang X, Qian X, Beitler JJ, Chen ZG, Khuri FR, Lewis MM, Shin HJ, Nie S, Shin DM.
Cancer Res. 2011;71:1526-1532.